|
- Rheumatoid Arthritis: Biologic Drugs at a Glance - WebMD
Biologic drugs are one type of medicine doctors use to treat moderate to severe rheumatoid arthritis (RA) They work on your immune system to ease inflammation and damage in your joints Use this
- Drugs for the Management of Rheumatoid Arthritis: Clinical Evaluation . . .
400 mg every 4 weeks can be used for a maintenance dose Almost never used to treat adult RA, according to the clinical expert Applications for approval have been withdrawn globally after sirukumab was not approved by the FDA Copyright © 2018 Canadian Agency for Drugs and Technologies in Health
- Biological Therapies for Rheumatoid Arthritis: An Overview for the . . .
There are five classes of bDMARDs currently available, each with a different molecular target and subtle differences in their efficacy and safety profile This review also describes the “real-world” use of bDMARDs and how they fit into the overall RA treatment guidelines Keywords: rheumatoid arthritis, biological therapies, bDMARDs
- Comparing the Effectiveness of Biologic Agents in the Treatment of . . .
The use of disease-modifying antirheumatic drugs (DMARDs) and the adoption of an early and aggressive treatment strategy have transformed the outcomes of patients with rheumatoid arthritis (RA)
- Which Biologic Therapies to Treat Active Rheumatoid Arthritis and When?
Hetland ML et al Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry
- Comparing Biologics for Rheumatoid Arthritis Treatment | AAFP
Results: A total of six Cochrane reviews comprising 31 studies were evaluated Most of the trials compared a biologic with placebo; both groups also received a traditional DMARD such as
- Treating Rheumatoid Arthritis: DMARDs and Biologics
According to the most recent treatment guidelines from the American College of Rheumatology, approved biologics for RA include etanercept (Enbrel), adalimumab (Humira), infliximab (Remicade),
- Comparison of Biologics for Rheumatoid Arthritis (RA)
Here is how they match up at attaining American College of Rheumatology’s ACR 50 which meant 50 percent improvement in the “number of tender or swollen joints and other doctor or patient assessed aspects of Rheumatoid Arthritis ”
|
|
|